Collegium Pharmaceutical Inc (COLL) Stock Forecast & Price Target
Collegium Pharmaceutical Inc · NASDAQ
$35.50+0.30 (+0.85%)
15-min delayed · Jul 27, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 4 firms covering Collegium Pharmaceutical Inc, 4 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets are tightly clustered, $48.00 to $60.00, so the covering firms are broadly aligned. The average target of $55.00 sits 55% above the current $35.50. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $2.09 next quarter toward $7.50 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS4 ratings
Moderate Buy
Strong Buy00%
Buy4100%
Hold00%
Sell00%
Strong Sell00%
Based on 4 analysts giving stock ratings to Collegium Pharmaceutical Inc.
As of Jul, 4 of 4 firms rate COLL a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
COLL EPS & revenue forecast
EPS · NEXT QUARTER
$2.09
Range $1.93 – $2.29 · 4 analysts · -7% YoY
Next period, 4 analysts expect Collegium Pharmaceutical Inc to earn $2.09 a share (range $1.93 – $2.29), versus $2.25 a year earlier. Full-year consensus is $7.76, growing to $7.50 the year after.
REVENUE · NEXT QUARTER
$232.9M
Range $224.7M – $241.1M · 4 analysts · +11% YoY
Revenue is expected to reach $232.9M (range $224.7M – $241.1M), +11.3% year-over-year. Full-year consensus is $869.9M, rising to $860.1M next year.
Top analysts covering Collegium Pharmaceutical Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on COLL.
#1
Serge Belanger
Needham · Rank #83
Buy
$56.00+57.7% to target
Overall win rate
48%
+ Follow
#2
David Amsellem
Piper Sandler · Rank #95
Hold
$44.00+23.9% to target
Overall win rate
50%
+ Follow
#3
Oren Livnat
HC Wainwright & Co. · Rank #142
Buy
$50.00+40.8% to target
Overall win rate
54%
+ Follow
#4
BF
Brandon Folkes
HC Wainwright & Co.
Buy
$60.00+69.0% to target
Coverage
—
+ Follow
#5
GS
Glen Santangelo
Barclays
Buy
$56.00+57.7% to target
Coverage
—
+ Follow
COLL stock forecast FAQ
What is COLL's average 12-month price target?+
The 4 analysts with a live target average $55.00 for Collegium Pharmaceutical Inc over the next 12 months, ranging from a $60.00 high to a $48.00 low.
Is COLL stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 4 analyst ratings, 4 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for COLL?+
The Street-high target is $60.00 (HC Wainwright & Co.), and the Street-low is $48.00 (Truist Securities). The average of all 4 active targets is $55.00.
How many Wall Street analysts cover COLL?+
4 analysts have an active rating on Collegium Pharmaceutical Inc, and 4 firms carry a live 12-month price target.
Who is the most accurate analyst covering COLL?+
Among analysts who currently cover COLL, Serge Belanger of Needham has the strongest overall Quantellect track record (Rank #83). Their current call is Buy with a $56.00 target.
What is Collegium Pharmaceutical Inc's projected EPS for next quarter?+
The consensus estimate is $2.09 per share (range $1.93 – $2.29) across 4 analysts. Full-year EPS is projected at $7.76, rising to $7.50 the following year.
How much revenue is Collegium Pharmaceutical Inc expected to report next quarter?+
Consensus revenue is $232.9M (range $224.7M – $241.1M). Full-year revenue is projected at $869.9M, growing to $860.1M next year.
Have analysts been upgrading or downgrading COLL lately?+
As of Jul, 4 of 4 firms rate COLL a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their COLL calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
